FY 2022 Financial Results Announced

Indivior PLC (LSE: INDV) announced its 2022 Full Year Results on February 16, 2023.

Rhea-AI Summary

Indivior PLC (LSE: INDV) announced its 2022 Full Year Results on February 16, 2023. The company aims to transform substance use disorders into recognized chronic diseases by providing evidence-based treatment worldwide. Indivior's product portfolio is available in 39 countries and includes treatments for opioid use disorders. Investors can access detailed earnings results, presentations, and webcasts on the company’s official website. The full earnings release can be found here.

Argus Session date unavailable

-11.09% session move Open Argus

Details

News Market Reaction – INVVY

The recorded move for INVVY in the trading session of this news was -11.09%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SLOUGH, England and RICHMOND, Va., Feb. 16, 2023 /PRNewswire/ -- Indivior PLC (LSE: INDV) today announced 2022 Full Year Results. The earnings release, investor presentation, and webcast are available at www.indivior.com.

• The earnings press release can be found at https://www.indivior.com/en/media/press-releases
• The investor presentation will be available at 7:00 am EST/12:00 GMT at https://www.indivior.com/investors

There will be a live webcast presentation on February 16, 2023, at 8:00 am EST/13:00 GMT. The details are below.

• The webcast event link is: https://edge.media-server.com/mmc/p/7wfjw5s4

Participants may access the presentation telephonically with the following link:

• https://register.vevent.com/register/BI6229b9170b5d4c04924cf0da6c6c7016

Registrants will have an option to be called back immediately prior to the call or be provided with a call-in # with a unique pin code following their registration.

About Indivior

Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat substance use disorders (SUD) and serious mental illnesses. Our vision is that all patients around the world will have access to evidence-based treatment for the chronic conditions and co-occurring disorders of SUD. Indivior is dedicated to transforming SUD from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of opioid use disorder treatments, Indivior has a pipeline of product candidates designed to both expand on its heritage in this category and potentially address other chronic conditions and cooccurring disorders of SUD. Headquartered in the United States in Richmond, VA, Indivior employs more than 900 individuals globally and its portfolio of products is available in 39 countries worldwide. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/indivior.

View original content to download multimedia:https://www.prnewswire.com/news-releases/fy-2022-financial-results-announced-301748321.html

SOURCE Indivior PLC

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What are the key highlights from Indivior's FY 2022 financial results?

Indivior announced its FY 2022 results on February 16, 2023, detailing performance metrics, revenue figures, and strategic initiatives.

When will the investor presentation for Indivior's 2022 results be available?

The investor presentation will be available at 7:00 am EST on February 16, 2023.

How can I access Indivior's earnings webcast?

The live webcast presentation can be accessed via Indivior's official website or directly through the webcast event link provided in the press release.